Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 7046 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives

John Mathew, Gopinath Deepa, Jagesh Rejitha

Year : 2016| Volume: 20| Issue : 1 | Page no: 22-31

   This article has been cited by
 
1 Comparative Efficacy and Safety Among Sodium-glucose Cotransporter-2 Inhibitors in Type 2 Diabetes – Results from a Retrospective Single-centre Study
Manash P Baruah,Sanjay Kalra
European Endocrinology. 2019; 15(2): 113
[Pubmed]  [Google Scholar] [DOI]
2 BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion
Sarita Bajaj,A. K. Das,Sanjay Kalra,Rakesh Sahay,Banshi Saboo,Sambit Das,M. Shunmugavelu,Jubbin Jacob,Gagan Priya,Deepak Khandelwal,Deep Dutta,Manoj Chawla,Vineet Surana,Mangesh Tiwaskar,Ameya Joshi,Pradip Krishna Shrestha,Jyoti Bhattarai,Bishwajit Bhowmik,Tint Swe Latt,Than Than Aye,G. Vijayakumar,Manash Baruah,Fatema Jawad,A. G. Unnikrishnan,Subhankar Chowdhury,Md. Faruqe Pathan,Noel Somasundaram,Manilka Sumanathilaka,Abbas Raza,Silver K. Bahendeka,Ankia Coetzee,Sundeep Ruder,Kaushik Ramaiya,Roberta Lamptey,Charlotte Bavuma,Khalid Shaikh,Andrew Uloko,Sandeep Chaudhary,Abdurezak Ahmed Abdela,Zhanay Akanov,Joel Rodrìguez-Saldaña,Raquel Faradji,Armindo Tiago,Ahmed Reja,Leszek Czupryniak
Diabetes Therapy. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors
Eugenio Cersosimo,John M. Miles
Current Diabetes Reviews. 2019; 15(4): 314
[Pubmed]  [Google Scholar] [DOI]
4 EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection
Rodrigo Postigo,Sabine Brosch,Jim Slattery,Anja van Haren,Jean-Michel Dogné,Xavier Kurz,Gianmario Candore,Francois Domergue,Peter Arlett
Drug Safety. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
Nobuya Inagaki,Shin-ichi Harashima,Kohei Kaku,Kazuoki Kondo,Nobuko Maruyama,Makiko Otsuka,Yutaka Kawaguchi,Hiroaki Iijima
Diabetes, Obesity and Metabolism. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Euglycemic Ketoacidosis With Sodium–Glucose Cotransporter-2 Inhibitor
Richard A. Koch,Richard F. Clark
American Journal of Therapeutics. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
7 Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial
Yasuo Terauchi,Masahiro Tamura,Masayuki Senda,Ryoji Gunji,Kohei Kaku
Diabetes, Obesity and Metabolism. 2017;
[Pubmed]  [Google Scholar] [DOI]
8 Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
Lyudmila Alexandrovna Ruyatkina,Maxim Sorokin
Diabetes mellitus. 2017; 20(2): 142
[Pubmed]  [Google Scholar] [DOI]
9 When Insulin Therapy Fails: The Impact of SGLT2 Inhibitors in Patients With Type 2 Diabetes
Stewart B. Harris,Selam Mequanint,Kristina Miller,Sonja M. Reichert,Tamara Spaic
Diabetes Care. 2017; 40(10): e141
[Pubmed]  [Google Scholar] [DOI]
10 Cardiovascular safety of therapies for type 2 diabetes
Puneet Gupta,William B. White
Expert Opinion on Drug Safety. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article